The news of Mizuho maintaining a Buy rating on Ovintiv is positive for the stock, but the lowering of the price target from $66 to $62 may have a neutralizing effect on the stock price in the short term. The analyst's opinion is important for investors, but the reduced price target may cause some uncertainty.